Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)
Clinical trial NCT00701389 · COMPLETED
Trial details
- NCT number
- NCT00701389
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-20
- Primary completion
- 2008-04-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.